Part I . Overview Olema is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of next-generation targeted therapies for breast cancer and beyond. We are advancing our pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (formerly known as OP-1250), is a novel, orally-available small molecule with dual acti...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-107169 | EDGAR | 112K words |
| 2025-03-18 | 2024-12-31 | 0000950170-25-041204 | EDGAR | — |
| 2024-03-11 | 2023-12-31 | 0000950170-24-029281 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001558370-23-003318 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001558370-22-002388 | EDGAR | — |
| 2021-03-17 | 2020-12-31 | 0001558370-21-003141 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-273236 | EDGAR | 76K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106565 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070374 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125427 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091836 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055686 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001558370-23-017994 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001558370-23-013936 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001558370-23-008815 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001558370-22-016903 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001558370-22-012930 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001558370-22-007860 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001193125-26-107154 | EDGAR | 1K words |
| 2026-01-30 | 0001193125-26-031792 | EDGAR | — |
| 2026-01-12 | 0001193125-26-010507 | EDGAR | — |
| 2025-11-19 | 0001193125-25-288343 | EDGAR | — |
| 2025-11-18 | 0001193125-25-286206 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273228 | EDGAR | — |
| 2025-10-20 | 0001193125-25-243765 | EDGAR | — |
| 2025-09-02 | 0001750284-25-000007 | EDGAR | — |
| 2025-08-11 | 0000950170-25-106545 | EDGAR | — |
| 2025-06-13 | 0000950170-25-086256 | EDGAR | — |
94 total filings indexed. 66 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001750284 |
| Ticker | OLMA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.olema.com |
| Listed | 2020-11-19 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report